MCA
Based on 1 Customer Validation
MCA (7-Methoxycoumarin-4-acetic acid) is a Coumarin (HY-N0709) derivative. MCA quantitates platelet-activating factor (PAF) by high-performance liquid chromatography with fluorescent detection. MCA can modify FRET peptide substrates for analyzing protease activities.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 98.87%
- CAS 番号: 62935-72-2
- 分子式: C12H10O5
- 分子量:234.21
-
保管条件:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
生物活性
Guide (The following is our recommended protocol. This protocol is only a guide and should be modified according to your specific needs).
1. FRET preparation[1]
1.1 Synthesize FRET substrates on TCP resin using Fmoc/tBu chemistry by fully automated solid-phase peptide synthesis.
1.2 Use a 7-fold molar excess of single Fmoc-L-amino acids for the coupling of standard D- or L-amino acids.
1.3 Perform Fmoc deprotections twice, each for 10 min, with 30% piperidine in dimethylformamide.
1.4 Couple Nα-Fmoc-N-ε-2,4-DNP-L-lysine [Fmoc-Lys(Dnp)] in 2-fold excess within 2 h with 1-H-benzotriazolium-1-[bis(dimethylamino) methylene]-5-chloro-tetrafluoro-borate(1-)3-oxide/Oxima Pure.
1.5 Modify the peptide resin with 7-methoxycoumarin-4-acetic acid (MCA). Carry out the coupling with five equivalents of MCA in dimethylformamide with diisopropylcarbodiimide/Oxima Pure within 3 h and monitor by Kaiser assay.
1.6 Cleave the FRET substrates off the resin within 4 h by treating the resins with trifluoroacetic acid/phenol/ethanedithiol/thioanisole/water (95:2:1:1:1), and then precipitate and wash them three times with diethylether.
1.7 Lyophilize the peptides in tert-butyl alcohol/water (4:1).
1.8 Characterize the FRET substrates analytically by reversed-phase HPLC-electrospray mass spectrometry to ensure the compound purity is greater than 85% (UV 214 nm).
1.9 Prepare the working solution with the prepared FRET substrates according to experimental requirements. For example, in some experiments, the final concentration of the FRET substrate is prepared to be 0.5 mM (when incubated with proteases).
2. Enzyme activity analysis
2.1 Produce recombinant catalytically active NSP4 (such as S-tag NSP4).
2.2 Add NSP4, NE, PR3, or CG at a final concentration of 6 mM to a commercial peptide library containing 0.5 mM FRET substrates in total.
2.3 Generate fluorescent signals by excitation at 320 nm and record them at 405 nm emission wavelength.
2.4 Only use the initial linear portion of the progress curve to calculate the enzymatic activity, expressed as relative fluorescence units per minute (increase of relative fluorescence units per minute). Set the value of the substrate that is cleaved best by the tested proteases to 100%, and present the average values with standard deviations as a percentage of this maximum value.
2.5 Analyze the cleaved fragments by liquid chromatography-tandem mass spectrometry after incubating for 5 and 30 min.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
450
345
化学情報
-
CAS 番号 62935-72-2
-
性状 Solid
-
分子量 234.21
-
分子式 C12H10O5
-
Color White to off-white
-
SMILES
O=C1OC(C=C(OC)C=C2)=C2C(CC(O)=O)=C1
-
別名
7-Methoxycoumarin-4-acetic acid
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
溶剤 & 溶解度
DMSO : 25 mg/mL (106.74 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (276 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
取扱説明書 (2659 KB)
参考文献
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 4.2697 mL | 21.3484 mL | 42.6967 mL | 106.7418 mL |
| 5 mM | 0.8539 mL | 4.2697 mL | 8.5393 mL | 21.3484 mL | |
| 10 mM | 0.4270 mL | 2.1348 mL | 4.2697 mL | 10.6742 mL | |
| 15 mM | 0.2846 mL | 1.4232 mL | 2.8464 mL | 7.1161 mL | |
| 20 mM | 0.2135 mL | 1.0674 mL | 2.1348 mL | 5.3371 mL | |
| 25 mM | 0.1708 mL | 0.8539 mL | 1.7079 mL | 4.2697 mL | |
| 30 mM | 0.1423 mL | 0.7116 mL | 1.4232 mL | 3.5581 mL | |
| 40 mM | 0.1067 mL | 0.5337 mL | 1.0674 mL | 2.6685 mL | |
| 50 mM | 0.0854 mL | 0.4270 mL | 0.8539 mL | 2.1348 mL | |
| 60 mM | 0.0712 mL | 0.3558 mL | 0.7116 mL | 1.7790 mL | |
| 80 mM | 0.0534 mL | 0.2669 mL | 0.5337 mL | 1.3343 mL | |
| 100 mM | 0.0427 mL | 0.2135 mL | 0.4270 mL | 1.0674 mL |